TaiGen Biotechnology's IPO

TaiGen Biotechnology raised a round of funding on January 21, 2014. Investors include Public.

TaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications.…

Articles about TaiGen Biotechnology's IPO: